Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Series C brings in $28.5mm for Baxano

Executive Summary

Spinal device company Baxano Inc. has raised $28.5mm out of a potential $30mm in its Series C equity financing led by first-time backer CMEA Capital, which was joined by other new investors Kaiser Permanente Ventures and Affinity Capital Management, returning shareholders Prospect Venture Partners, Three Arch Partners, and Kearny Venture Partners, and six undisclosed investors. The company will apply the money towards the US launch of its iO-Flex system for lumbar stenosis and for post-clearance clinical trials.

Deal Industry
  • Medical Devices
  • Medical Devices
    • Surgical Equipment & Devices
      • Minimally or Less Invasive
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies